Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Carboplatin Taxol Avastin in Ovarian Cancer (OVCA)

This study has been completed.
Women and Infants Hospital of Rhode Island
Information provided by:
Massachusetts General Hospital Identifier:
First received: August 10, 2005
Last updated: August 7, 2009
Last verified: August 2009
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: February 2009
  Primary Completion Date: February 2009 (Final data collection date for primary outcome measure)